Valeant Plummets on Allegation of Enron-Like Accounting – Bloomberg

Valeant Plummets on Allegation of Enron-Like Accounting – Bloomberg


Bloomberg

Valeant Plummets on Allegation of Enron-Like Accounting
Bloomberg
Valeant Pharmaceuticals International Inc. shares took a beating, falling more than 20 percent, after a stock-commentary site run by a short seller accused the company of an Enron-like strategy of recording fake sales by using phony customers.
Valeant Pharmaceuticals (VRX) In Accounting Fraud: CitronValueWalk
SHORT SELLER: Here's why pharmaceutical company Valeant looks like EnronBusiness Insider

all 120 news articles »

Valeant Plummets on Allegation of Enron-Like Accounting – Bloomberg